Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)

Market Cap	2.51B +28.4%
Revenue (ttm)	584.68M -7.8%
Net Income	-98.88M
EPS	-0.34
Shares Out	289.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,704,583
Open	8.60
Previous Close	8.70
Day's Range	8.48 - 9.24
52-Week Range	5.30 - 9.72
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About Jiangsu Nanfang Medical

Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, sports protective equipment, first aid kits, nitrile gloves, and protective equipment in China and internationally. The company offers medical proof fabrics, care products, band-aids, and applications; medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1990
• Employees: 789
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603880

Financial Performance

In 2025, Jiangsu Nanfang Medical's revenue was 600.51 million, a decrease of -0.35% compared to the previous year's 602.62 million. Losses were -101.71 million, -46.66% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 24, 2026

Data Sources Report a data error